0
Preliminary Program
Preliminary Program: Monday, May 24
Psychiatric News
Volume 45 Number 4 page 21-24
+

Industry-Supported Breakfast Symposia

+

Registration/Course Enrollment Open

+

CME Courses 41-48

+

+

Advances in Medicine

AM01. Delirium: Neurobiology, Prevention, and Treatment ApproachesChair: Jose R. Maldonado, M.D.

+

Case Conference 1

Robert Ursano, M.D., on Posttraumatic Stress Disorder (PTSD) (Open to APA members only.)

+

Lectures

L4. Vestermark Award LectureGlen O. Gabbard, M.D.

L5. The Perplexities and Provocations of Eating DisordersKatherine A. Halmi, M.D.

+

Scientific and Clinical Reports

Session 6. Psychotherapy and Depression

SCR16. Sudden Gains in Supportive Expressive Psychotherapy in Depression: A Replication and Extension Dahlia Mukherjee, M.A.

SCR17. Short-Term Psychodynamic Psychotherapy Versus Pharmacotherapy Versus Pill Placebo for Major Depressive Disorder in an Urban, Disadvantaged Sample Jacques Barber, Ph.D.

SCR18. The Relation of Specific, Common, and Unintended Factors to Outcome in Psychodynamic Therapy for Depression Kevin McCarthy, M.A.

Session 7. Borderline Personality Disorder and Emotion Dysregulation

SCR19. Neural Sensitization as a Possible Mechanism of Emotional Reactivity: A Comparison of Borderline and Avoidant Personality Disorder and Healthy Controls Harold Koenigsberg, Investigator

SCR20. Short-Term Versus Term Dialectical Behavior Therapy for Patients With Borderline Personality Disorder: Predictors of Response and Elements of Choice Nader Perroud, M.D.

SCR21. Dysregulated Brain Networks in the Cognitive Control of Emotion in Borderline Personality Disorder: An fMRI Study Harold Koenigsberg, M.D.

+

Small Interaction Sessions

SI01. Terence A. Ketter, M.D., on Diagnosis and Evidence-Based Treatment of Bipolar Disorder (Meet the Author)

SI02. Dilip V. Jeste, M.D., on Successful Cognitive and Emotional Aging: How Can We Get There? (Meet the Author)

SI03. Steven S. Sharfstein, M.D., on The Crisis of Access to Psychiatrists in an Era of Health Reform

SI04. Timothy Lineberry, M.D., on Suicide and Suicide Risk Assessment: Practical Information and Application

+

Focus Live 1

Steven B. Levine, M.D., on Disorders of Sleep, Eating, and Sex

New Research Young Investigators' Poster Session 1

+

Workshops

W59. Interviewing Patients Who Hate or Fear PsychiatristsChair: James L. Griffith, M.D.

W60. Patients as Practice Partners:Catalyzing Recovery Through CollaborationChair: Peter Buckley, M.D.

W61. Disaster Preparedness, Evacuation, and Rebuilding: Lessons Learned From Katrina Applied to Gustav and IkeChair: Erich Conrad, M.D.

W62. The Explosion of Social Media: Why, Where, When, and How Can Psychiatrists Catch Up With the Trend?APA Council on Communications; Chair: Gabriela Cora, M.D.

W63. Treating the Aggressive Child and Teen: Integrated Techniques for Management and InterventionCo-Chairs: Niranjan Karnik, M.D., Hans Steiner, M.D.

W64. Guided Self-Help, A New Intervention to Overcome Anxiety ComplaintsChair: Christine Van Boeijen, M.D.

W65. Preventing Late-Life Sequelae Resulting From Early-Life TraumaChair: Erikka Dzirasa, M.D.

W66. Behavioral Complications of Dementia: A Comprehensive Multidisciplinary Treatment ApproachChair: Sanjay Vaswani, M.D.

W67. Core Competencies in Europe and the United States of America: An Educational ModelCo-Chairs: Pedro Ruiz, M.D., Deborah Hales, M.D.

W68. Writing for the ‘Blue Journal’: The Residents' and Fellows' Edition of theAmerican Journal of Psychiatry Chair: Robert Freedman, M.D.

W69. A Resident's Guide to Borderline Personality Disorder From the Experts: Part IChair: John Gunderson, M.D.(Open to residents only.)

W70. If a Patient Googles Me, What Will They Find?—The Information Age and Its Impact on Residency TrainingCo-Chairs: Don Hilty, M.D., Deborah Cabaniss, M.D.

+

+

Advances in Series

A01. Advances in Correctional Psychiatry From Provision of Care to Malpractice PreventionChair: Charles Scott, M.D.

A02. Advances in Psychosomatic MedicineChair: James L. Levenson, M.D.

+

Presidential Symposium

PS02. Comparative Effectiveness of Psychotropic Drugs: What Can We Learn From Practical Clinical Trials?American Psychiatric Publishing Inc.; Editorial Board Chair: Jeffrey Lieberman, M.D.

    +
  • Bipolar Affective Disorder: Lithium Anticonvulsant Comparative Evaluation (BALANCE): An International, Open-Label, Randomized, Clinical Trial John Geddes, M.D.

  • Lithium Moderate Dose Study (LiTMUS): A Practical Clinical Trial for Bipolar Disorder Andrew Nierenberg, M.D.

  • Practical Clinical Trials in Schizophrenia T. Scott Stroups, M.D.

  • Practical Clinical Trials in Child and Adolescent Psychiatry John Walkup, M.D.

  • Practical Clinical Trials in Child and Adolescent Psychiatry John S. March, M.D.

  • The FDA's Perspective on Comparative Efficacy and Safety Jing Zhang, M.D.

  • +

    Symposium

    S42. Update on Medications Development: Promising New Treatments for Drug AddictionNational Institute on Drug Abuse

      +
  • Modafinil as a Novel Medication in the Treatment of Cocaine Addiction Charles O'Brien, M.D.

  • D-Cycloserine in the Treatment of Cocaine and Nicotine Dependence Kathleen Brady, M.D.

  • Bupropion for the Treatment of Methamphetamine Addiction David J. McCann, Ph.D.

  • Dronabinol for Cannabis Addiction Treatment Frances R. Levin, M.D.

  • NicVAX: An Innovative Vaccine Treatment for Nicotine Addiction Raafat Fahim, Ph.D.

  • +

    CME Courses 49-55

    +

    Advances in ResearchHerbert Pardes, M.D.

    +

    Exhibits Open

    APA Member Center Open

    Publishers' Bookfair Open

    +

    +

    Advances in Medicine

    AM02. Top 10 Medical Articles of 2009: A Comprehensive and Practical Review of What We Need to KnowChair: Monique Yohanan, M.D.

    +

    Focus Live 02

    Marc Rappaport, M.D., on Psychotherapy

    +

    Forums

      +
  • Piano Forum—Chopin at 200: His Mind and His MusicChair: Richard Kogan, M.D.

  • DSM-5: Progress in Research and DevelopmentDavid J. Kupfer, M.D.

  • +

    Lectures

    L7. Neuroimaging Clue to the Causes of Bipolar Disorder: Where We Are and Where We Are GoingStephen M. Strakowski, M.D.

    L8. Optogenetics: Developmentand ApplicationKarl Deisseroth, M.D., Frontiers of Science Lecture

    +

    Small Interactive Sessions

    SI05. Donald Goff, M.D., on Antipsychotic Polypharmacy: An Evidence-Based Perspective

    SI06. Silvia Karasu, M.D., on The Gravity of Weight: The Impossible Heaviness of Being (Meet the Author)

    SI07. Barbara Coffey, M.D., on Child Psychopharmacology: SSRIs, Stimulants, and Safety Issues

    SI08. James Rundell, M.D., on Delirium Assessment and Management

    +

    Workshops

    W71. American Board of Psychiatry and Neurology Update: Certification in Psychiatry and Its SubspecialtiesChair: Larry R. Faulkner, M.D.

    W72. Transcranial Magnetic Stimulation in Clinical Practice: A Pragmatic Approach to a New Psychiatric ProcedureChair: Timothy Derstine, M.D.

    W73. To File or Not to File: Guardianship for Older Adults With DementiaCo-Chairs: Asghar Ali, M.D., Sheila LoboPrabhu, M.D.

    W74. The Vicissitudes of the Doctor-Patient Relationship in Modern Medicine: Endurance, Erosion, or TransformationChair: Robert C. Joseph, M.D.

    W75. When Is Psychiatric Illness Terminal?Co-Chairs: Melinda Henderson, M.D., Kate Payne, J.D.

    W76. Neonaticide: Phenomenology and PreventionChair: Renee Sorrentino, M.D.

    W77. Integrating CAM (Complementary Alternative Medicine) in Psychiatric Care: New Paradigms and PerspectivesChair: Simon Chiu, M.D.

    W78. The Use of Research Measures in Clinical PracticeChair: Joan Busner, Ph.D.

    W79. Taking It Personal: Integrating Pharmacogenetics Into the Management of DepressionChair: Sheldon H. Preskorn, M.D.

    W80. Telepsychiatry and theChanging Face of Access for Rural America's Children and AdolescentsAPA Council on Children, Adolescents, and Their Families; Chair: L. Charolette Lippolis, D.O.

    W81. Guardianship and Powers of Attorney: Issues in Geriatric PsychiatryCo-Chairs: David Casey, M.D., Robert Roca, M.D.

    W82. Practical Pharmacotherapy of Mood DisordersCo-Chairs: Gary Miller, M.D., Richard Noel, M.D.

    +

    Scientific and Clinical Reports

    Session 8. Borderline Personality Disorder

    SCR22. Gender Differences in the Development of Borderline Personality Disorder Uday Patil, M.A.

    SCR23. Recurrent Suicide Attempts and Medical Lethality in Borderline Personality Disorder Paul Soloff, M.D.

    SCR24. Time to Attainment of Recovery From Borderline Personality Disorder and Its Stability: A 10-Year Prospective Follow-Up Study Mary Zanarini, Ed.D.

    Session 9. Childhood Abuse

    SCR25. Clinical Phenomenology of Childhood Abuse—Related Complex PTSD Patients: Differential Patterns of Personality Disturbance Ethy Dorrepaal, M.D.

    SCR26. Effect of Cognitive-Behavioral Stabilizing Group Treatment on Brain Activity in Childhood Abuse—Related Complex PTSD Patients Kathleen Thomaes, M.D.

    SCR27. Childhood Maltreatment in Women With Binge Eating Disorder: Associations With Psychiatric Comorbidity, Psychological Functioning, and Eating Pathology Daniel Becker, M.D.

    +

    Exhibit Hall Open

    +

    New Research Young Investigators' Poster Session 2

    +

    CME Courses 57-64

    +

    +

    Lectures

    L8. Adolf Meyer Award LectureSolomon H. Snyder, M.D.

    L9. Your Bipolar Dad Is a Bad Reason to Become a Psychiatrist: Advocacy Adventures of a Bewildered Boy Who Grew Up to Become NAMI's Medical DirectorKenneth S. Duckworth, M.D.

    +

    +

    Scientific and Clinical Reports

    Session 10. Cognitive Disorders

    SCR28. Incidence Rates and Probability to Develop Dementia and Alzheimer's Disease in a Southern European City: The Zarademp Project Antonio Lobo, M.D.

    SCR29. Art and Dementia: Pathological and Clinical Features of Different Subtypes of Dementia, With a Focus on the Changes in Art Production Laura Safar, M.D.

    SCR30. Metacognitive Capacity Mediates of the Impact of Neurocognitive Deficits on Function in Schizophrenia Paul Lysaker, Ph.D.

    Session 11. Diagnostic Issues andDSM-5

    SCR31. Intellectual Disability in DSM-5 Walter Kaufmann, M.D.

    SCR32. Adding Dimensional Assessments of Psychopathology to Psychiatric Diagnoses: Implications for DSM-5 William Narrow, M.D.

    SCR33. Nosology for Beginners: Historical and Current Perspectives on the Fundamental Issues and Problems in the Classification of Psychiatric Disorders Avram Mack, M.D.

    +

    Workshops

    W83. Malpractice Defense: Strategies for SuccessCo-Chairs: Abe Rychik, J.D., Eugene Lowenkopf, M.D.

    W84. The Psychiatrist's Role in Integrating Primary Care and Behavioral Health Care: Friend or Foe?Chair: Ruth Shim, M.D.

    +

    +

    Focus Live 3

    Genetics and GenomicsCo-Chairs: Carlos Pato, M.D., Michele Pato, M.D.

    +

    +

    Advances in Series

    A03. Advances in Forensic PsychiatryChair: Robert I. Simon, M.D.

    A04. Advances in Psychotherapeutic TreatmentsChair: Glen O. Gabbard, M.D.

    +

    Media Workshop

    MW3. "Patrik, Age 1.5": A Swedish Film About Unexpected and Gay AdoptionAmerican Academy of Child and Adolescent Psychiatry; Chair: Richard Pleak, M.D.

    +

    Presidential Symposium

    PS03. Can Basic and Translational Neuroscience Improve Treatment in Psychiatry?Co-Chairs: Alan F. Schatzberg, M.D., Karl Deisseroth, M.D.

      +
  • Translational Studies in Genetics: Genetic Tools in Animal Models to Understand Heritable Risk Factors in Depression and Posttraumatic Stress Disorder Kerry Ressler, M.D.

  • Emotion Regulation: Toward a Neurobiological Understanding of Psychotherapy Amit Etkin, M.D.

  • Optogenetics: Development and Application Karl Deisseroth, M.D.

  • Using Optogenetic Tools and Information Theory to Elucidate Prefrontal Microcircuit Dysfunction in Schizophrenia Vikaas Sohal, M.D.

  • +

    Symposia

    S43. Early Detection and Intervention in Schizophrenia: An Idea Whose Time Has Come

      +
  • Early Intervention in Psychiatry: Lessons From Psychosis Patrick McGorry, M.D.

  • Why Treating Early, Treating Well, and Treating for Life Is Important in Schizophrenia Renée Kahn, M.D.

  • Selective and Indicated Prevention for Schizophrenia: An NIMH Perspective on Current and Future Possibilities Robert Heinssen, M.D.

  • Portland Identification and Early Referral (PIER): Prevention of Psychosis as a Public Health Intervention William McFarlane, M.D.

  • At Clinical High Risk for Psychosis—What Is the Outcome? Jean Addinton, Ph.D.

  • Early Detection and Intervention in Psychotic Disorders: Making It Ready for Prime Time Jeffrey Lieberman, M.D.

  • S44. An Examination of CNS Trial Methodologies

      +
  • Placebo Response Is Not Necessarily Response to Placebo: Factors Inflating Placebo Response in CNS Trials Armin Szegedi, M.D.

  • Does De-Coupling of Entry Criteria Improve Outcomes in CNS Trials? Charlotte Kremer, M.D.

  • Comparison of Site-Based Versus Centralized Ratings in a Study of Generalized Anxiety Disorder (GAD) Judith Dunn, Ph.D.

  • Evaluation of Centralized Ratings in a Clinical Trial of Major Depressive Disorder (MDD) Steven D. Targum, M.D.

  • The Use of Independent Assessments for Patient Eligibility for CNS Trials Maurizio Fava, M.D.

  • S45. Interpersonal and Social Rhythm Therapy (IPSRT) for Bipolar Disorder: New Applications, New Populations, and New Evidence

      +
  • Comparison of IPSRT Monotherapy and Quetiapine for the Treatment of Bipolar II Depression: A Proof of Concept Trial Holly A. Swartz, M.D.

  • Early Intervention for Adolescent Offspring of Parents With Bipolar Disorder: Pilot Study of Interpersonal and Social Rhythm Therapy (IPSRT) Tina Goldstein, Ph.D.

  • Interpersonal and Social Rhythm Therapy for Adolescents With Bipolar Disorder: Treatment Development and Results From an Open Trial Stefanie A. Hlastala, Ph.D.

  • IPSRT for Bipolar Disorder in the Perinatal Period Suzanne Luty, Ph.D.

  • S46. Ensuring a Public Health Impact: Partnering With Consumers and Community Stakeholders to Improve Access and Quality of Care for Mental Disorders

      +
  • A Public Health Initiative Address Depression and Posttraumatic Stress Disorder in a Post-Disaster Setting Benjamin Springgate, M.D.

  • CBPR in the Arkansas Delta: Developing an Implementation Partnership With Rural Underserved Community Health Centers Justin B. Hunt, M.D.

  • A Partnership for Wellness: Addressing Stress and Violence in West and Southwest Philadelphia Glenda Wrenn, M.D.

  • GROOVI Care: A Community Coalition to Engage With Veterans of Operations Enduring Freedom and Iraqi Freedom (OEF/OIF) About Their Mental Health Patrick E. Link, M.D.

  • Using a Community-Partnered Participatory Research Approach to Implement a Randomized, Controlled Trial: Designing of Community Partners in Care Bowen Chung, M.D.

  • S47. New Studies Appear in the JuneAmerican Journal of Psychiatry—Presentations by the Authors and Editors

    S48. Reducing Harm: Safer Injection and Other Strategies

      +
  • Creating An Inclusive Drug Strategy: The Experience of Establishing Vancouver's Supervised Injection Site Liz Evans, B.S.N.

  • S49. Advances in the Treatment of Bipolar Disorder

      +
  • Advances in Maintenance Treatment of Bipolar Disorder Terence A. Ketter, M.D.

  • Advances in Treatment of Bipolar Depression Po W. Wang, M.D.

  • Treatment of Children and Adolescents With Bipolar Disorder Kiki Chang, M.D.

  • Treatment of Pregnant Women With Bipolar Disorder Katherine E. Williams, M.D.

  • Management of Bipolar Disorders in Older Adults John Brooks, Ph.D.

  • S50. Challenges in Providing Mental Health Care for College and University StudentsAPA Council on Children, Adolescents, and Their Families

      +
  • The Magnitude of Clinical Demands Jerald Kay, M.D.

  • Discussant Victor I. Schwartz, M.D.

  • Psychiatric Hospitalization and Follow-Up Care of the College Student Rachel L. Glick, M.D.

  • Violence Assessment and Administrative Responses Gregory T. Eells, Ph.D.

  • Managing the Suicidal College Student Morton Silverman, M.D.

  • S51. Geriatric Psychopharmacology of Late-Life Mood Disorders: Focus on the Use of Biomarkers as Predictors of Response

      +
  • Psychopharmacology of Geriatric Depressions: The Use of Aging Biomarkers to Predict Treatment Response Helen Lavretsky, M.D.

  • Geriatric Bipolar Disorder: Clinical Diagnosis and Treatment Martha Sajatovic, M.D.

  • The Use of Structural MRI as a Predictor of Antidepressant Response in Older Adults Yvette Sheline, M.D.

  • S52. Innovations in Integrated Treatment of Substance Use and Psychiatric DisordersNational Institute on Drug Abuse

      +
  • Integrated Treatment of Depression and Substance Use Disorders in Adolescents Paul Rohde, Ph.D.

  • Posttraumatic Stress Disorder and Drug Abuse: Etiology and Treatment Linkages Kathleen Brady, M.D.

  • Integrated Group Therapy for Patients With Co-Occurring Bipolar Disorder and Substance Use Disorder Roger D. Weiss, M.D.

  • Advances in Pharmacotherapy for Comorbid Depression and Addictions Edward V. Nunes, M.D.

  • Treatment of Cannabis Use Disorder in Patients With Schizophrenia Alan I. Green, M.D.

  • S53. Genotypes and Biomarkers—The New Decision Makers for Tailored Treatment

      +
  • Introduction to Session Florian Holsboer, M.D., Ph.D.

  • Genetic and Other Biomarkers of Antidepressant Outcome Francis McMahon, M.D.

  • Individualized Antipsychotic Therapy for Schizophrenic Patients Edwin J.C.G. van den Oord, Ph.D.

  • Gene Expression Profile in Persons Exposed to the WTC With and Without PTSD Rachel Yehuda, Ph.D.

  • S54. Substance Related Disorders inDSM-5:Progress Report

      +
  • The Search for Specific Criteria: A Report From the Criterion Subcommittee Marc Schuckit, M.D.

  • Abuse and Dependence: Combining the Disorders Into a Single Category Deborah S. Hasin, Ph.D.

  • Non Substance-Related Addictions: Their Place in DSM-5 Nancy M. Petry, Ph.D.

  • Terminology of Substance Use Disorders for DSM-5 Wilson M. Compton III, M.D.

  • Severity of Substance Use Disorders Thomas J. Crowley, M.D.

  • S55.DSM-5Update Series, Part I: Reports From the Work Groups

      +
  • Approaches to the Diagnosis and Classification of Eating Disorders in DSM-5 B. Timothy Walsh, M.D.

  • Key Recommendations From the DSM-5 Sexual and Gender Identity Disorders Work Group Kenneth J. Zucker, Ph.D.

  • Update From the Somatic Symptoms Work Group Joel E. Dimsdale, M.D.

  • Toward a Better, Practical Understanding of Sleep Disturbances in People Living With or at Risk for Mental Illness Charles Reynolds, M.D.

  • Neurocognitive Disorders in DSM-5 Dilip V. Jeste, M.D.

  • S56. Focal Brain Stimulation for Psychiatric Disorders: Clinical Update

      +
  • The Clinical Safety and Efficacy of Transcranial Magnetic Stimulation: Results From Recent Pivitol Clinical Trials William M. McDonald, M.D.

  • Clinical Update on Magnetic Seizure Therapy (MST) Sarah H. Lisanby, M.D.

  • Clinical Update on Vagus Nerve Stimulation (VNS) Linda L. Carpenter, M.D.

  • The Promise of Direct Epidural Cortical Stimulation (DCS) in Refractory MDD: The PROSPECT Experience and Future Directions Jerry L. Halverson, M.D.

  • Deep Brain Stimulation for Psychiatric Disorders: Clinical Update Paul Holtzheimer, M.D.

  • S57. Depression, Metabolic Syndrome, and Obesity

      +
  • Depression and Abdominal Obesity Brenda Penninx, Ph.D.

  • Depression and Diabetes: A Potentially Lethal Comorbidity Wayne J. Katon, M.D.

  • Brain Correlates of Comorbid Diabetes and Geriatric Depression Anand Kumar, M.D.

  • Depression Is Associated With Increased Severity of Comorbidities in Bariatric Surgical Candidates Mohamed R. Ali, M.D.

  • Should Mood Syndromes Be Reclassified as Metabolic Syndrome Type II? Roger S. McIntyre, M.D.

  • S58. Neurobiology of Obesity: Why We Can Get Too Motivated to EatNational Institute on Drug Abuse; Chair: Joseph Frascella, Ph.D.

      +
  • Overview of Why We Eat Too Much David Kessler, M.D.

  • Central Control of Food Intake: Appetite Control and the Reward Driven Hans-Rudolf Berthoud, Ph.D.

  • Sweetness as a Super Reward: Comparison With Cocaine and Heroin Serge Ahmed, Ph.D.

  • Individual Differences in the Neurophysiology of Reward and the Obesity Epidemic Dana Small, Ph.D.

  • Neurocircuitry of Addiction and Obesity Nora D. Volkow, M.D.

  • +

    New Research Poster Session 3

    +

    +

    Scientific and Clinical Reports

    Session 12. Psychosomatics and Cardiac Vulnerability

    SCR34. Sex Differences in the SAD-HART CHF Trial Jonathan Lee, M.D.

    SCR35. Psychosomatic Medicine and the Philosophy of Life Michael Schwartz, M.D.

    SCR36. Broken Hearts: Cardiovascular and Emotional Stress Measures in Relocated Katrina Survivors Phebe Tucker, M.D.

    Session 13. Addictive Behavior

    SCR37. Disparities in Substance Abuse Prevalence: Is It Time to Strategize and Refocus? Deepak Prabhakar, M.D.

    SCR38. Pathological Gambling: An Impulse Control Disorder? Measurement of Impulsivity Through Neurocognitive Tests Pinhas Dannon, M.D.

    SCR39. Quitting Cannabis Use Without Formal Treatment in Adults David Gorelick, M.D.

    +

    Workshops

    W85. Teaching Psychiatry in New Medical SchoolsChair: Marcia Verduin, M.D.

    W86. Deafness—Disability or Difference? The Cultural and Clinical Needs of Deaf PatientsAPA/SAMHSA Minority Fellows; Co-Chairs: Neil Aggarwal, M.D., Christopher Tjoa, M.D.

    +

    +

    Convocation of Distinguished Fellows

    Carrie Fisher, William C. Menninger Memorial Lecture

    +

    +

    Media Workshop

    MW4. National Disasters: Developing a Road Map for Preparedness and InterventionsWorld Psychiatric Association; Chair: Arshad Husain, M.D.blacksquare

    Interactive Graphics

    Video

    NOTE:
    Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
    Related Articles
    Articles